BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 31194880)

  • 1. Antibiotic therapy for chronic infection with Burkholderia cepacia complex in people with cystic fibrosis.
    Frost F; Shaw M; Nazareth D
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD013079. PubMed ID: 31194880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic therapy for chronic infection with Burkholderia cepacia complex in people with cystic fibrosis.
    Frost F; Shaw M; Nazareth D
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD013079. PubMed ID: 34889457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis.
    Smith S; Rowbotham NJ
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD001021. PubMed ID: 36373968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
    Langton Hewer SC; Smith S; Rowbotham NJ; Yule A; Smyth AR
    Cochrane Database Syst Rev; 2023 Jun; 6(6):CD004197. PubMed ID: 37268599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatments for preventing recurrence of infection with Pseudomonas aeruginosa in people with cystic fibrosis.
    Palser S; Smith S; Nash EF; Agarwal A; Smyth AR
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD012300. PubMed ID: 31845758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exercise versus airway clearance techniques for people with cystic fibrosis.
    Heinz KD; Walsh A; Southern KW; Johnstone Z; Regan KH
    Cochrane Database Syst Rev; 2022 Jun; 6(6):CD013285. PubMed ID: 35731672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.
    Horsley A; Jones AM; Lord R
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD009529. PubMed ID: 26789750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.
    Horsley A; Jones AM
    Cochrane Database Syst Rev; 2012 Oct; 10():CD009529. PubMed ID: 23076960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.
    Lord R; Jones AM; Horsley A
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD009529. PubMed ID: 32239690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
    Langton Hewer SC; Smyth AR
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD004197. PubMed ID: 28440853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eradication therapy for Burkholderia cepacia complex in people with cystic fibrosis.
    Regan KH; Bhatt J
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD009876. PubMed ID: 30997925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-acting inhaled bronchodilators for cystic fibrosis.
    Smith S; Rowbotham NJ; Edwards CT
    Cochrane Database Syst Rev; 2022 Jun; 6(6):CD013666. PubMed ID: 35749226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis.
    Aslam AA; Sinha IP; Southern KW
    Cochrane Database Syst Rev; 2023 Mar; 3(3):CD012040. PubMed ID: 36866921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eradication therapy for Burkholderia cepacia complex in people with cystic fibrosis.
    Regan KH; Bhatt J
    Cochrane Database Syst Rev; 2016 Nov; 11():CD009876. PubMed ID: 27804115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eradication therapy for Burkholderia cepacia complex in people with cystic fibrosis.
    Regan KH; Bhatt J
    Cochrane Database Syst Rev; 2014 Oct; (10):CD009876. PubMed ID: 25342425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interventions for improving adherence to airway clearance treatment and exercise in people with cystic fibrosis.
    Jones M; Moffatt F; Harvey A; Ryan JM
    Cochrane Database Syst Rev; 2023 Jul; 7(7):CD013610. PubMed ID: 37462324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis.
    Southern KW; Patel S; Sinha IP; Nevitt SJ
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010966. PubMed ID: 30070364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
    Langton Hewer SC; Smyth AR
    Cochrane Database Syst Rev; 2014 Nov; (11):CD004197. PubMed ID: 25383937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis.
    Smith S; Rowbotham NJ; Regan KH
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD001021. PubMed ID: 29607494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probiotics for people with cystic fibrosis.
    Coffey MJ; Garg M; Homaira N; Jaffe A; Ooi CY
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012949. PubMed ID: 31962375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.